May 13, 2025 05:50 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
US, China agree to pause tariff war for 90 days, will slash reciprocal duties by 115 percent | India struck Malir Cantonment in Karachi: IAF's big revelation on Operation Sindoor | Nuclear blackmailing will not be tolerated, Operation Sindoor not over: PM Modi in address to nation | Military bases, equipment, systems operational, ready for next mission if required: Armed Forces on Operation Sindoor | India's cricket icon Virat Kohli retires from Test cricket | Secretary of State Marco Rubio says US position on Russia-Ukraine war remains on reaching 'immediate ceasefire' | Trade war de-escalation: US, China decide to roll back most tariffs for 90 days | India and Pakistan agreed to stop military actions: Govt confirms Trump's ceasefire claim | India, Pakistan have reached full and immediate ceasefire: Donald Trump announces on Truth Social | 'Frivolous allegation': India dismisses Pakistan's 'Indian missiles hit Afghanistan' disinformation
PharmEasy

Goldman Sachs likely to invest Rs 2,700 crore in PharmEasy parent: Report

| @indiablooms | May 18, 2022, at 10:32 pm

Goldman Sachs is in the advanced stages of talks to invest $350 million (Rs 2,700 crore) in API Holdings, the promoter of online pharmacy company PharmEasy, ET reported.

The investment will be in a structured debt transaction and carry an interest rate of 14-15 percent, the report said.

The debt will also have a pre-agreed equity upside or a premium to the increase in the company's valuation.

The money borrowed will mainly be used to refinance the debt the company took to acquire diagnostics chain Thyrocare last in 2021.

Further, API Holdings may raise another $200 million after the deal closure with Goldman Sachs.

PharmEasy is India's largest online pharmacy had plans to raise Rs 6,200 crore through an initial public offering (IPO) of shares. But the plan was kept due to weak market conditions, the report said.

Of the money raised through IPO, Rs 1929 crore would have been used in paying off debt, it added.

The online pharmacy was valued at $5.6 billion when a host of global funds invested $350 million in a pre-IPO round in October last year.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm
PM Modi on Budget 2024 Jul 23, 2024, at 09:30 pm
Close menu